Somerset NHS Foundation Trust

The Somerset NHS Foundation Trust incorporates Musgrove Park Hospital in Taunton https://www.somersetft.nhs.uk/

View Trust Services

This trust offers the following services:

  • Acute services:
    • On-site bowel stenting facilities
  • Diagnostic and pre-operative services:
    • On-site PET-CT facilities
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Routine Genetic Testing for Lynch Syndrome
  • Advanced disease services:
    • Dedicated Specialist Advanced MDT
    • Complex vascular reconstruction
  • Support service facilities:
    • Dedicated nurses for ERAS services
    • Availability of 24 hour palliative care advice
    • On-site psychology services

Data Quality

All Patients: Trust Network National
Number of patients in Audit 204 1851 35779
Case ascertainment (%) Fair Good Good
Data completeness of:
– Pre-treatment TNM (%) 93 95 86
– Performance status (%) 97 96 89
Patients having major resection: Trust Network National
Number of patients in Audit 23 778 19631
ASA grade 1 (%) 4 9 9
ASA grade 2 (%) 43 57 53
ASA grade 3 (%) 35 31 31
ASA grade 4+ (%) N/A 1 2
ASA grade not recorded (%) 17 1 4
Data completeness of:
7 Audit items for risk-adjustment (%) 30 80 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients

All Patients: Trust Network National
Number of patients in Audit 204 1851 35779
Seen by Clinical Nurse Specialist (%) 98 89 88

Management of patients having major resection

Patients having major resection: Trust Network National
Number of patients in Audit 23 778 19614
Distant metastases (%) 11 4 5
Urgent or emergency surgery (%) 9 13 15
At least 12 lymph nodes excised (%) 33 73 84
Laparoscopic surgery attempted (%) 91 80 72
Risk-adjusted length of stay > 5 days (%) 41 49 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 49 N/A 10747
Adjuvant chemotherapy (%) 69 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit 36 N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) 29 N/A 22

Rectal cancer patients

Patients having major resection: Trust Network National
Number of patients in Audit N/A N/A 4251
Neoadjuvant therapy (%) 24 N/A 33
Circumferential resection margin: Recorded (%) N/A 81 89
Circumferential resection margin: Negative (%) N/A 69 83
Rectal volume 16 N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 119 1041 19644
APER/Hartmanns (%) 51 33 37

Compare trust outcomes